← Evidence map

ArticleJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2022

Net benefit of ivacaftor during prolonged tezacaftor/elexacaftor exposure in vitro.

Ciaran A Shaughnessy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35248469